BioAtla Earning Date (BCAB)

USA |NASDAQ |USD

BCAB Earnings Date

|
Report Date Period Ending EPS Forecast Last Quarter's EPS Last Year's EPS
- Sep 30, 2021 - $-0.90 -
Report Date Period Ending Revenue Forecast Last Quarter’s Revenue Last Year’s Revenue
- Sep 30, 2021 - $250.00K $150.00K

BCAB Earnings Date & History Chart

BCAB Earnings & Revenue Forecast

BCAB Earnings Forecast

|
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 4 $-3.54 $-3.98 $-2.82

BCAB Earnings Revision Trend

|
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Period End Up/Down 1M 1M Trend 2M Trend 3M Trend
Dec 2022 0 / 0 $-3.54 $-3.54 $-2.48

BCAB Revenue Forecast

|
Period End # of Analysts Revenue Forecast Low Revenue Forecast High Revenue Forecast
Period End # of Analysts EPS Forecast Low EPS Forecast High EPS Forecast
Dec 2022 5 $7.60M $0.00 $10.00M

BCAB Earnings Date & Revenue History

BCAB Earnings History

|
Show More
Show More

BCAB Revenue History

|
Show More
Show More

Bioatla Next Earnings Date & Report

BCAB Aug 2021 (FQ) Earnings Date & Report Preview

Bioatla Previous Earnings Dates & Reports

BCAB Previous Earnings Date & Report Recap: Jun 2021 (FQ)

Bioatla's previous earnings date was Aug 13, 2021 for its fiscal quarter ended Jun 30, 2021.

BCAB's earnings per share (EPS) was $-0.90, missing the consensus analysts forecast of $-0.56 by -60.71%.

The EPS was lower than the previous fiscal quarter (Mar 2021) by 60.71%.

Revenues were $250.00K.

The company reported a net income of $-30.38M.

Free cash flow for the quarter was $-13.78M , compared to $-15.49M last quarter and $-3.12M a year before.

BCAB ended the quarter with $682.00K in total debt, an increase of 0.00% compared to the previous quarter.

BCAB Previous Earnings Date & Report Recap: Dec 2020 (FY)

Bioatla's previous annual earnings date was Mar 24, 2021 for its fiscal year ended Dec 31, 2020.

BCAB's earnings per share (EPS) was $-0.87.

Revenues were $429.00K, worse than the forecast of $1.71M by -74.91%, and down by -91.75% from previous year's revenue.

The company reported a net income of $-35.85M.

Bioatla reported a free cash flow of $-36.92M for its fiscal year, compared to $-11.15M a year ago.

The company ended the fiscal year with $1.36M in total debt, a decrease of -92.47% compared to the previous year.